← Back to headlines
Inhibrx Biosciences Reports Positive Interim Phase 2 Results
Inhibrx Biosciences (INBX) has announced positive interim results from the Phase 2 portion of its HexAgon Study.
14 May, 16:52 — 14 May, 16:52
Sources
Showing 1 of 1 sources
